Patients who progress to the most severe form of CD, AACD (previously CTLN2), display clinical symptoms associated with hyperammonemia, namely, neuropsychiatric symptoms, which can progress to coma and brain edema [43]. This evidence concerns the gene SLC25A13 and Hyperammonemia.